hims and hers tirzepatide The FDA announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company & to yank its new compounded semaglutide (Wegovy) weight-loss pill from the Hims & Hers tirzepatide π¨
Pay in 4 interest-free payments of $5.80 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 30 - Sep 4

























